LAS-30813

N/A

Report date: 2023/01/08 21:47:44
NME

Base Information

Drug NameLAS-30813
Drug Alias NameLAS-30813
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlmirall Sa
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A